Literature DB >> 19910536

Impact of diastolic dysfunction on the development of heart failure in diabetic patients after acute myocardial infarction.

Doron Aronson1, Anees Musallam, Jonathan Lessick, Saleem Dabbah, Shemy Carasso, Haim Hammerman, Shimon Reisner, Yoram Agmon, Diab Mutlak.   

Abstract

BACKGROUND: Diabetes is often associated with an abnormal diastolic function. However, there are no data regarding the contribution of diastolic dysfunction to the development of heart failure (HF) in diabetic patients after acute myocardial infarction. METHODS AND
RESULTS: A total of 1513 patients with acute myocardial infarction (417 diabetic) underwent echocardiographic examination during the index hospitalization. Severe diastolic dysfunction was defined as a restrictive filling pattern (RFP) based on E/A ratio >1.5 or deceleration time <130 ms. The primary end points of the study were readmission for HF and all-cause mortality. The frequency of RFP was higher in patients with diabetes (20 versus 14%; P=0.005). During a median follow-up of 17 months (range, 8 to 39 months), 52 (12.5%) and 62 (5.7%) HF events occurred in patients with and without diabetes, respectively (P<0.001). There was a significant interaction between diabetes and RFP (P=0.04) such that HF events among diabetic patients occurred mainly in those with RFP. The adjusted hazard ratio for HF was 2.77 (95%, CI 1.41 to 5.46) in diabetic patients with RFP and 1.21 (95% CI, 0.75 to 1.55) in diabetic patients without RFP. A borderline interaction (P=0.059) was present with regard to mortality (adjusted hazard ratio, 3.39 [95% CI, 1.57 to 7.34] versus 1.61 [95% CI, 1.04 to 2.51] in diabetic patients with and without RFP, respectively).
CONCLUSIONS: Severe diastolic dysfunction is more common among diabetic patients after acute myocardial infarction and portends adverse outcome. HF and mortality in diabetic patients occur predominantly in those with concomitant RFP.

Entities:  

Mesh:

Year:  2009        PMID: 19910536     DOI: 10.1161/CIRCHEARTFAILURE.109.877340

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  11 in total

Review 1.  Biomechanics of Cardiac Function.

Authors:  Andrew P Voorhees; Hai-Chao Han
Journal:  Compr Physiol       Date:  2015-09-20       Impact factor: 9.090

2.  Empagliflozin and left ventricular diastolic function following an acute coronary syndrome in patients with type 2 diabetes.

Authors:  Nick S R Lan; Bu B Yeap; P Gerry Fegan; Gillian Green; James M Rankin; Girish Dwivedi
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-21       Impact factor: 2.357

Review 3.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.

Authors:  Sumanth D Prabhu; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

Review 4.  Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.

Authors:  Ilaria Russo; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2015-12-15       Impact factor: 5.000

Review 5.  Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.

Authors:  Amit Saxena; Ilaria Russo; Nikolaos G Frangogiannis
Journal:  Transl Res       Date:  2015-07-17       Impact factor: 7.012

Review 6.  The inflammatory response in myocardial injury, repair, and remodelling.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419

7.  The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction.

Authors:  Lawien Al Ali; Minke T Hartman; Chris P H Lexis; Yoran M Hummel; Erik Lipsic; Joost P van Melle; Dirk J van Veldhuisen; Adriaan A Voors; Iwan C C van der Horst; Pim van der Harst
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

8.  The relation between serum phosphorus levels and clinical outcomes after acute myocardial infarction.

Authors:  Doron Aronson; Michael Kapeliovich; Haim Hammerman; Robert Dragu
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

9.  Preconditioning diabetic mesenchymal stem cells with myogenic medium increases their ability to repair diabetic heart.

Authors:  Mohsin Khan; Fatima Ali; Sadia Mohsin; Shoaib Akhtar; Azra Mehmood; Mahmood S Choudhery; Shaheen N Khan; Sheikh Riazuddin
Journal:  Stem Cell Res Ther       Date:  2013-05-24       Impact factor: 6.832

10.  Fenofibrate plus Metformin Produces Cardioprotection in a Type 2 Diabetes and Acute Myocardial Infarction Model.

Authors:  Víctor Hugo Oidor-Chan; Enrique Hong; Francisca Pérez-Severiano; Sergio Montes; Juan Carlos Torres-Narváez; Leonardo Del Valle-Mondragón; Gustavo Pastelín-Hernández; Alicia Sánchez-Mendoza
Journal:  PPAR Res       Date:  2016-03-16       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.